Skip to main content

Table 4 Correlation between ribavirin dose reduction or discontinuation and PCR for HCV week 24 (SVR rate)

From: Study the response of Qurevo (ombitasvir, paritaprevir, and ritonavir) in end-stage renal disease patients with hepatitis C virus

PCR for HCV, week 24 Ribavirin dose reduction or discontinuation Chi-square
Yes No Total
N % N % N % X2 P-value
Positive 0 0.00 2 4.35 2 4.00 0.181 0.670
Negative 4 100.00 44 95.65 48 96.00
Total 4 100.00 46 100.00 50 100.00